SIBO is usually diagnosed by a combination of symptoms and by abnormal hydrogen or methane gas exhalation
after consumption of a measured amount of glucose or lactulose.
Direct sampling of small bowel bacteria via aspiration is sometimes considered the "gold standard,"
but this specialty test "is not readily available in most clinical settings and is limited by a high
contamination rate" [Lim2023 🕮 ].
Glucose breath testing is more specific to upper small intestine (duodenem) bacterial overgrowth [cite needed]
while lactulose testing is more sensitive to lower small intestine (illium) bacterial overgrowth [cite needed].
Dr. Weyrich hypothesizes that the glucose breath testing is more likely to identify problems with digestive
fluid production, such as hypochlorhydria, exocrine pancreatic insufficiency, or hepatobilliary insufficiency,
while the lactulose testing is more sensitive to illiocecal valve dysfunction.
Dr. Weyrich uses
Genova Diagnostics
for glucose testing. At this time he has not identified an appropriate lab for lactulose testing.